Celltrion accelerates Japan push with newly approved biosimilars
--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-03-27 15:55 UTC+10:00
Section: All News
Factuality Score: 90
Opinion Category: Neutral
Topics: Health, Asia, Labour & Workers, World News, Asia Pacific
--------------------------------------------------------------------
Snippet:
Celltrion announced Friday that it has obtained product approval from the Japanese Ministry of Health, Labor and Welfare for Omlyclo, a biosimilar of allergic disease treatment Xolair, and Eydenzelt, a biosimilar of the ophthalmic disease treatment Eylea.
--------------------------------------------------------------------